Department of Health and Human Services
National Institutes of Health
Toggle navigation
Search
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
How to Search
Contact Us
Search the Studies
Go Back
Searched Result
61 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Protocol Number
Title
Protocol Status
Min-Max Age
Institute
Keywords
001092-C
Exploring the Role of Palliative Care in Phase 1 Enrolled Pediatric Oncology Patients
Enrolling by Invitation
18-125 Years
NCI
Et
000867-CC
Humanitarian Use Device (HUD) Protocol for Use of Miltenyi CliniMACS (Registered Trademark) CD34 Reagent System in AML
Participants currently recruited/enrolled
0-125 Years
CC
Et
000491-C
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
Participants currently recruited/enrolled
18-125 Years
NCI
Et
000272-H
Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults
Participants currently recruited/enrolled
5-45 Years
NHLBI
Et
000193-C
Phase 1 Study of Copanlisib with Dose-adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and other High-Grade B-cell Lymphomas
Clinical hold/Recruitment or enrollment suspended
18-125 Years
NCI
Et
21-C-0014
Phase 1 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination with Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
Participants currently recruited/enrolled
18-125 Years
NCI
Et
20-M-0157
PET Imaging of Cyclooxygenase in Participants with Major Depressive Disorder (MDD)
Participants currently recruited/enrolled
18-70 Years
NIMH
Et
20-H-0049
NHLBI DIR Cardiovascular Branch PK Papyrus Covered Stent Ethics Oversight of Humanitarian Use Device for Treatment of Acute Perforations of Native Coronary Arteries and Coronary Bypass Grafts in Vessels 2.5 to 5.0 mm in Diameter
Enrolling by Invitation
18-125 Years
NHLBI
Et
20-C-0098
A Phase 1/2, Open Label, Dose-Escalation, Safety and Tolerability Study of NC410 in Subjects with Advanced or Metastatic Solid Tumors
Completed Study; data analyses ongoing
18-125 Years
NCI
Et
19-C-0103
A Study of Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas with Secondary Involvement of the Central Nervous System (CNS)
Participants currently recruited/enrolled
18-125 Years
NCI
Et
19-C-0025
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
Enrolling by Invitation
18-125 Years
NCI
Et
18-H-0108
Vascular Disease Discovery Protocol
Participants currently recruited/enrolled
2-100 Years
NHLBI
Et
18-CH-0001
Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder
Participants currently recruited/enrolled
0-65 Years
NICHD
Et
16-CC-0112
Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted with Cobicistat in Healthy Volunteers
Completed Study; data analyses ongoing
18-65 Years
CC
Et
16-CC-0001
Evaluation of MiSeq for Microbial Identification in Specimens
Enrolling by Invitation
2-125 Years
CC
Et
15-HG-0049
Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol
Completed Study; data analyses ongoing
14-50 Years
NHGRI
Et
15-H-0190
Human Biospecimen Procurement and Analysis to Support Translational Research to Identify Genetic Etiology and Disease Mechanism(s) in Rare Genetic Vascular/Cardiovascular Diseases
Participants currently recruited/enrolled
0-125 Years
NHLBI
Et
14-N-0086
Deep Brain Stimulation Therapy in Movement Disorders
Participants currently recruited/enrolled
18-125 Years
NINDS
Et
14-I-0020
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Participants currently recruited/enrolled
18-65 Years
NIAID
Et
14-EI-0064
Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions
Participants currently recruited/enrolled
1-125 Years
NEI
Et
14-CC-0027
The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients with Interstitial Lung Disease
Participants currently recruited/enrolled
21-80 Years
CC
Et
14-C-0157
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, Rituximab (TEDDI-R) in Primary CNS Lymphoma
Participants currently recruited/enrolled
18-125 Years
NCI
Et
14-C-0004
A Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 (Ibrutinib) for Treatment of Relapsed Hairy Cell Leukemia
No longer recruiting/follow-up only
18-125 Years
NCI
Et
13-DK-0090
Identifying Risk for Diabetes and Heart Disease in Women: A Study of African-American, African and White Federal Employees and Contractors
Completed Study; data analyses ongoing
25-65 Years
NIDDK
Et
12-HG-0022
Inherited Diseases, Caregiving, and Social Networks
Completed Study; data analyses ongoing
18-125 Years
NHGRI
Et
12-H-0110
An Open-label, Non-Randomized, Single-Arm Pilot Study to Evaluate the Effectiveness of Etidronate Treatment for Arterial Calcifications due to Deficiency in CD73 (ACDC)
Completed Study; data analyses ongoing
18-80 Years
NHLBI
Et
12-DK-0097
Energy Expenditure Responses to Different Temperatures
Participants currently recruited/enrolled
18-75 Years
NIDDK
Et
11-I-0109
Viral Infections in Healthy and Immunocompromised Hosts
Participants currently recruited/enrolled
0-125 Years
NIAID
Et
10-DK-N091
Molecular and Clinical Profile of Diabetes Mellitus and its Complications
Participants currently recruited/enrolled
18-125 Years
NIDDK
Et
10-C-0011
Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas
Completed Study; data analyses ongoing
18-125 Years
NCI
Et
09-I-0102
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Participants currently recruited/enrolled
18-125 Years
NIAID
Et
09-HG-0009
Participant Reactions to Disease Risk Information
Completed Study; data analyses ongoing
25-40 Years
NHGRI
Et
08-AA-0178
Computer-Assisted Self-Administration of Ethanol (CASE) in Humans
Participants currently recruited/enrolled
21-60 Years
NIAAA
Et
05-C-0252
Phase III Randomized Study of R-CHOP v. Dose-Adjusted EPOCH-R with Molecular Profiling in Untreated de Novo Diffuse Large B-Cell Lymphomas
Completed Study; data analyses ongoing
18-125 Years
NCI
Et
04-HG-0211
Analysis of Specimens from Individuals with Pulmonary Fibrosis
Participants currently recruited/enrolled
18-125 Years
NHGRI
Et
04-HG-0127
Clinical and Basic Investigations of Methylmalonic Acidemia (MMA) and Related Disorders
Participants currently recruited/enrolled
0-125 Years
NHGRI
Et
04-AR-0205
Progression of Spinal Fusion in Ankylosing Spondylitis
Completed Study; data analyses ongoing
18-125 Years
NIAMS
Et
03-M-0211
Family Study of Affective and Anxiety Spectrum Disorders
Participants currently recruited/enrolled
7-120 Years
NIMH
Et
02-C-0212
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Completed Study; data analyses ongoing
18-100 Years
NCI
Et
02-C-0178
Multidisciplinary Etiologic Study of Familial Testicular Cancer
No longer recruiting/follow-up only
12-125 Years
NCI
Et
02-C-0052
Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study
Participants currently recruited/enrolled
0-125 Years
NCI
Et
01-M-0254
The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers
Participants currently recruited/enrolled
3-99 Years
NIMH
Et
01-I-0202
Natural History, Genetics, Phenotype, and Treatment of Mycobacterial Infections
Participants currently recruited/enrolled
0-100 Years
NIAID
Et
01-DK-N117
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Clinical hold/Recruitment or enrollment suspended
18-125 Years
NIDDK
Et
01-C-0030
Short-Course EPOCH - Rituximab in Untreated CD-20+ HIV-Associated Lymphomas
No longer recruiting/follow-up only
18-125 Years
NCI
Et
01-AR-0227
Studies of the Natural History of Rheumatic Disease in Minority Communities
Participants currently recruited/enrolled
18-100 Years
NIAMS
Et
00-N-0140
A Prospective Natural History Study of VHL Patients with CNS Hemangioblastomas
No longer recruiting/follow-up only
8-75 Years
NINDS
Et
00-I-0159
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Participants currently recruited/enrolled
0-125 Years
NIAID
Et
00-HG-0209
Molecular and Clinical Studies of Primary Immunodeficiency Diseases
No longer recruiting/follow-up only
3-125 Years
NHGRI
Et
00-C-0074
Evaluation of Late Effects and Natural History of Disease in Patients Treated with Radiotherapy
Participants currently recruited/enrolled
18-125 Years
NCI
Et
98-D-0145
Screening and Natural History of Patients with Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome
Participants currently recruited/enrolled
0-100 Years
NIDCR
Et
97-HG-0192
Genetic Studies in the Amish and Mennonites
Completed Study; data analyses ongoing
18-125 Years
NHGRI
Et
95-M-0097
An Endocrine Model for Postpartum Mood Disorders
Participants currently recruited/enrolled
18-50 Years
NIMH
Et
95-HG-0193
Clinical and Basic Investigations into Hermansky-Pudlak Syndrome
Participants currently recruited/enrolled
0-125 Years
NHGRI
Et
94-HG-0132
The Phenotype and Etiology of Proteus Syndrome
Participants currently recruited/enrolled
0-125 Years
NHGRI
Et
94-DK-0127
Pathogenesis of Glomerulosclerosis
Completed Study; data analyses ongoing
2-125 Years
NIDDK
Et
94-C-0074
Treatment and Natural History Study of Lymphomatoid Granulomatosis
Participants currently recruited/enrolled
12-125 Years
NCI
Et
93-C-0133
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Adults and Children with Previously Untreated Patients with Aggressive Non-Hodgkin's Lymphoma
No longer recruiting/follow-up only
12-125 Years
NCI
Et
92-M-0174
The Central Nervous System Effects of Pharmacologically Induced Hypogonadotropic Hypogonadism with and without Estrogen and Progesterone Replacement
Completed Study; data analyses ongoing
18-50 Years
NIMH
Et
90-M-0088
The Treatment of Menstrually-Related Mood Disorders with the Gonadotropin Releasing Hormone (GnRH) Agonist, Depot Leuprolide Acetate (Lupron)
Completed Study; data analyses ongoing
18-45 Years
NIMH
Et
78-C-0039
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
No longer recruiting/follow-up only
0-125 Years
NCI
Et